Growing community of inventors

South San Francisco, CA, United States of America

Yoong Wearn Lim

Average Co-Inventor Count = 7.41

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Yoong Wearn LimDavid Scott Johnson (6 patents)Yoong Wearn LimAdam Shultz Adler (5 patents)Yoong Wearn LimMichael Asensio (5 patents)Yoong Wearn LimRena Aviva Mizrahi (4 patents)Yoong Wearn LimKacy Stadtmiller (3 patents)Yoong Wearn LimSheila Keating (3 patents)Yoong Wearn LimAngelica V Medina-Cucurella (3 patents)Yoong Wearn LimAriel Niedecken (3 patents)Yoong Wearn LimEmily Benzie (3 patents)Yoong Wearn LimMatthew James Spindler (2 patents)Yoong Wearn LimEllen Wagner (1 patent)Yoong Wearn LimAyla Lynn Nelson (1 patent)Yoong Wearn LimErica Lyn Stone (1 patent)Yoong Wearn LimRobert Edgar (1 patent)Yoong Wearn LimTaylor Weller (1 patent)Yoong Wearn LimYoong Wearn Lim (6 patents)David Scott JohnsonDavid Scott Johnson (27 patents)Adam Shultz AdlerAdam Shultz Adler (19 patents)Michael AsensioMichael Asensio (5 patents)Rena Aviva MizrahiRena Aviva Mizrahi (17 patents)Kacy StadtmillerKacy Stadtmiller (3 patents)Sheila KeatingSheila Keating (3 patents)Angelica V Medina-CucurellaAngelica V Medina-Cucurella (3 patents)Ariel NiedeckenAriel Niedecken (3 patents)Emily BenzieEmily Benzie (3 patents)Matthew James SpindlerMatthew James Spindler (7 patents)Ellen WagnerEllen Wagner (5 patents)Ayla Lynn NelsonAyla Lynn Nelson (1 patent)Erica Lyn StoneErica Lyn Stone (1 patent)Robert EdgarRobert Edgar (1 patent)Taylor WellerTaylor Weller (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Gigagen, Inc. (4 from 21 patents)

2. Gigamune, Inc. (2 from 4 patents)


6 patents:

1. 12421311 - Anti-CTLA-4 binding proteins and methods of use thereof

2. 12404607 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof

3. 12371689 - Engineered enveloped vectors and methods of use thereof

4. 11718660 - Recombinant polyclonal proteins targeting Zika and methods of use thereof

5. 11685779 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof

6. 11421220 - Engineered cells expressing anti-viral T cell receptors and methods of use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/17/2025
Loading…